Loretta Nastoupil
0000-0001-6071-8610
22 papers found
Refreshing results…
Encouraging activity for R-CHOP in advanced stage nodular lymphocyte–predominant Hodgkin lymphoma
Lenalidomide, idelalisib, and rituximab are unacceptably toxic in patients with relapsed/refractory indolent lymphoma
Missing publications? Search for publications with a matching author name.